A federal agency is recruiting volunteers for a study seeking a vaccine against H7N9.
H7N9 is a strain of avian influenza that has not reached humans in the United States--yet.
The National Institutes of Health wants a vaccine ready for any H7N9 pandemics.
The Phase 2 clinical trial will last 16 months.
